Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years — United States, August 13, 2021–November 19, 2021
Hannah E. Fast, Elizabeth R. Zell, Bhavini Patel Murthy, Neil Murthy, Lu Meng, Lynn Gibbs Scharf, Carla L. Black, Lauren Shaw, Terence Chorba, LaTreace Harris
Abstract
Coverage was similar by sex and age group, but varied by primary series vaccine product and race and ethnicity, ranging from 30.3% among non-Hispanic American Indian or Alaska Native persons to 50.5% among non-Hispanic multiple/other race persons. Strategic efforts are needed to encourage eligible persons aged ≥18 years, especially those aged ≥65 years and those who are immunocompromised, to receive a booster and/or additional primary dose to ensure maximal protection against COVID-19.
Topics & Concepts
MedicineVaccinationBooster (rocketry)Booster doseDemographyPediatricsVirologyImmunizationImmunologyAntibodyAstronomySociologyPhysicsSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies